CTA
NVRO

Carillon Tower Advisers’s NEVRO CORP. NVRO Stock Holding History

Carillon Tower Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$32.6M Buy
188,585
+56,190
+42% +$9.1M 0.2% 155
2020
Q3 		$18.4M Buy
132,395
+8,678
+7% +$1.16M 0.25% 149
2020
Q2 		$14.8M Buy
+123,717
New +$14.7M 0.11% 250

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Carillon Tower Advisers's NVRO Position: Q4 2020 in Review

Carillon Tower Advisers increased its NEVRO CORP. (NVRO) stake by 42% in Q4 2020, buying an estimated $9.1M and bringing the position to 188,585 shares worth $32.6M. The position accounts for 0.2% of the portfolio, ranked #155.

Carillon Tower Advisers first reported a position in NVRO in Q2 2020 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • Carillon Tower Advisers held 188,585 shares of NEVRO CORP. worth $32.6M as of Q4 2020.
  • Carillon Tower Advisers bought 56,190 NEVRO CORP. shares in Q4 2020, an estimated $9.1M.
  • NEVRO CORP. made up 0.2% of Carillon Tower Advisers's portfolio in Q4 2020, its #155 holding.
  • Carillon Tower Advisers first reported a position in NEVRO CORP. in Q2 2020 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.